Zacks Investment Research
27 Aug 2026, 14:16 UTC · 2w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Medtronic's upcoming quarterly earnings are expected to be $1.39 per share, a 10.3% increase year-over-year. — Strong double-digit EPS growth generally supports a positive price reaction, though it is already priced into the consensus.
+0.30Analysts forecast Medtronic's quarterly revenues to reach $9.47 billion, representing a 10.4% increase year-over-year. — Consistent revenue growth indicates healthy demand across the company's product lines.
+0.20Medtronic's Cardiovascular revenue is projected to grow by 15.2% to $3.78 billion. — High growth in a primary business segment is a positive fundamental signal for the stock.
+0.15Continue reading
5 related stories
Search tags
There has been no revision in the consensus EPS estimate for Medtronic over the past 30 days. — Lack of revisions suggests stability in expectations and a lack of new catalyst information.
Which stocks this story touches
Analysts forecast growth in quarterly earnings and revenue, with positive projections across most major business segments.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
9h ago
